Table 2.
FLS Model | Proportion investigated with BMD testing | Proportion initiated on osteoporosis treatment |
---|---|---|
Type A: 3i FLS model | 79% | 46% |
Type B: 2i FLS model | 60% | 41% |
Type C: 1i FLS model | 43% | 23% |
Type D: ‘Zero I’ FLS model | - | 8% |
Reproduced with kind permission of Springer